This morning the Food and Drug Administration approved Luxturna, a gene therapy to treat a rare form of blindness in kids and adults that will be sold by Philadelphia-based Spark...
Read More
In the latest in a string of deals pairing insurers with healthcare providers, health insurer Humana and two private equity companies will divide and buy long-term care and home healthcare...
Read More
Next year looks — at least on paper — like an unprecedentedly good setup for the pharmaceutical industry. But behind the scientific breakthroughs, a Food and Drug Administration churning out approvals...
Read More
Health Reform: The CVS Health bid to buy Aetna will "reshape" health care, or so headlines would have us believe. Actually, it's a sign that the health care landscape is already...
Read More
Plot your transition. Will 2018 be the year you finally retire and say goodbye to your job forever? If so, the next few months will come and go faster than you...
Read More
This week some of America’s most beloved internet companies will follow the footsteps of Big Tobacco and Wall Street in a dreaded rite of passage: the Capitol Hill perp walk....
Read More
There hasn’t been a year in recent memory packed with as much change as we have witnessed in 2017. This groundswell of disruption stands poised to continue into the year...
Read More
As an entrepreneur or small-business owner, social media should be a top priority. From promoting your products to building a community to developing your brand's voice -- the benefits of having a solid grasp on your...
Read More